glp-1 risks The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management | Current Cardiovascular Risk Reports GLP-1 and Low Blood Pressure:

Cardiovascular Benefits: Clinical studies have demonstrated that Ozempic can reduce the risk of major adverse cardiovascular events, such as heart attacks and strokes

Milk samples were collected 0, 12, and 24 hours after subcutaneous semaglutide administration

Potential effects of bariatric surgery on the incidence of heart failure and atrial fibrillation in patients with type 2 diabetes mellitus and obesity and on mortality in patients with preexisting heart failure: a nationwide, matched, observational cohort study

Mann JFE, Rossing P, Bakris G et al (2024) Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial